{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T20:00:28Z","timestamp":1781726428127,"version":"3.54.5"},"reference-count":44,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,11,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Venous thromboembolism (VTE) is associated with inferior survival in cancer patients. The risk of VTE and its effect on survival in chronic lymphocytic leukemia (CLL) patients remains unclear. The present study investigated the impact of patient-related factors, CLL prognostic markers, and CLL treatment on the risk of VTE and assessed overall survival relative to VTE. All patients in the Danish National CLL Registry (2008-2015) were followed from the date of CLL diagnosis to death, VTE, emigration, or administrative censoring. Hazard ratios (HRs) were estimated using Cox models, and second primary cancers and anticoagulation treatment were included as time-varying exposures. During a median follow-up of 2.6 years, 92 VTEs occurred among 3609 CLL patients, corresponding to a total incidence rate of 8.2 VTEs per 1000 person-years (95% confidence interval [CI], 6.7-10.1). A history of VTE or second primary cancer was associated with HRs of VTE of 5.09 (95% CI, 2.82-9.17) and 3.72 (95% CI, 2.15-6.34), respectively, while \u03b22-microglobulin &amp;gt;4 mg\/L, unmutated immunoglobulin HV and unfavorable cytogenetics had lower HRs. CLL patients with VTE had marginally higher mortality, which was most pronounced among patients &amp;lt;60 years of age (HR, 7.74; 95% CI, 2.12-28.29). Our findings suggest that markers of unfavorable CLL prognosis contribute to an increased risk of VTE; however, previous VTE or a second primary cancer is more strongly associated with the risk of VTE than any CLL-specific marker. Focusing attention on this preventable complication may improve survival in young CLL patients.<\/jats:p>","DOI":"10.1182\/bloodadvances.2018023895","type":"journal-article","created":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T16:51:24Z","timestamp":1542127884000},"page":"3025-3034","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":18,"title":["Venous thromboembolism in chronic lymphocytic leukemia: a Danish nationwide cohort study"],"prefix":"10.1182","volume":"2","author":[{"given":"Inger Lise","family":"Gade","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine, Aalborg University, Aalborg, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe Juul","family":"Riddersholm","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Intensive Care and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilse","family":"Christiansen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Aalborg University Hospital, Aalborg, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Rewes","sequence":"additional","affiliation":[{"name":"Department of Hematology, Odense University Hospital, Odense, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Frederiksen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Odense University Hospital, Odense, Denmark;"},{"name":"Department of Hematology, Hospital of Southern Denmark, Aabenraa, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisbeth","family":"Enggaard","sequence":"additional","affiliation":[{"name":"Department of Hematology, Herlev Hospital, Herlev, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Bj\u00f8rn","family":"Poulsen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Roskilde Hospital, Roskilde, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav Jonas","family":"Bergmann","sequence":"additional","affiliation":[{"name":"Department of Hematology, Vejle Hospital, Vejle, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorte Balle","family":"Gillstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Hematology, Aarhus University Hospital, Aarhus, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Schou","family":"Pedersen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Holstebro Hospital, Holstebro, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Esbjerg Hospital, Esbjerg, Denmark; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle H\u00f8jmark","family":"Eriksen","sequence":"additional","affiliation":[{"name":"Unit of Epidemiology and Biostatistics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Torp-Pedersen","sequence":"additional","affiliation":[{"name":"Unit of Epidemiology and Biostatistics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren Risom","family":"Kristensen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Aalborg University, Aalborg, Denmark;"},{"name":"Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne Tang","family":"Severinsen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Aalborg University, Aalborg, Denmark;"},{"name":"Department of Hematology, Aalborg University Hospital, Aalborg, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2018,11,13]]},"reference":[{"issue":"1","key":"2020021108392693000_B1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1182\/blood-2014-02-556399","article-title":"Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia","volume":"124","author":"Pflug","year":"2014","journal-title":"Blood"},{"issue":"6","key":"2020021108392693000_B2","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1470-2045(16)30029-8","article-title":"An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data","volume":"17","author":"International CLL-IPI working group","year":"2016","journal-title":"Lancet Oncol"},{"issue":"17","key":"2020021108392693000_B3","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1182\/blood-2016-07-724740","article-title":"The CLL-IPI applied in a population-based cohort","volume":"128","author":"da Cunha-Bang","year":"2016","journal-title":"Blood"},{"issue":"25","key":"2020021108392693000_B4","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJM200012213432504","article-title":"Prognosis of cancers associated with venous thromboembolism","volume":"343","author":"S\u00f8rensen","year":"2000","journal-title":"N Engl J Med"},{"key":"2020021108392693000_B5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2147\/PPA.S79373","article-title":"Patients\u2019 experiences of LIving with CANcer-associated thrombosis: the PELICAN study","volume":"9","author":"Noble","year":"2015","journal-title":"Patient Prefer Adherence"},{"key":"2020021108392693000_B6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.thromres.2017.09.002","article-title":"Epidemiology of venous thromboembolism in hematological cancers: The Scandinavian Thrombosis and Cancer (STAC) cohort","volume":"158","author":"Gade","year":"2017","journal-title":"Thromb Res"},{"issue":"6","key":"2020021108392693000_B7","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.thromres.2015.05.010","article-title":"Venous thromboembolism in patients with chronic lymphocytic leukemia","volume":"136","author":"\u0160imkovi\u010d","year":"2015","journal-title":"Thromb Res"},{"issue":"3","key":"2020021108392693000_B8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.leukres.2010.11.011","article-title":"Chronic lymphocytic leukaemia is a risk factor for venous thromboembolism","volume":"35","author":"Whittle","year":"2011","journal-title":"Leuk Res"},{"issue":"3","key":"2020021108392693000_B9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1538-7836.2006.01804.x","article-title":"Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study","volume":"4","author":"Blom","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2020021108392693000_B10","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.ejca.2012.10.021","article-title":"Incidence of venous thromboembolism in patients with cancer: a cohort study using linked United Kingdom databases","volume":"49","author":"Walker","year":"2013","journal-title":"Eur J Cancer"},{"issue":"6","key":"2020021108392693000_B11","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"},{"issue":"5","key":"2020021108392693000_B12","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/bjc.2013.381","article-title":"Increased risk of second malignancies in chronic lymphocytic leukaemia patients as compared with follicular lymphoma patients: a Canadian population-based study","volume":"109","author":"Beiggi","year":"2013","journal-title":"Br J Cancer"},{"issue":"6","key":"2020021108392693000_B13","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1200\/JCO.2008.17.5398","article-title":"Other malignancies in chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"27","author":"Tsimberidou","year":"2009","journal-title":"J Clin Oncol"},{"issue":"6","key":"2020021108392693000_B14","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/annonc\/mdw072","article-title":"Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia","volume":"27","author":"Falchi","year":"2016","journal-title":"Ann Oncol"},{"issue":"1","key":"2020021108392693000_B15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/ijc.22672","article-title":"Risk of second cancer after chronic lymphocytic leukemia","volume":"121","author":"Sch\u00f6llkopf","year":"2007","journal-title":"Int J Cancer"},{"key":"2020021108392693000_B16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"issue":"7 Suppl","key":"2020021108392693000_B17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The danish national prescription registry","volume":"39","author":"Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"issue":"7 suppl","key":"2020021108392693000_B18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The Danish Civil Registration System","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand J Public Health"},{"issue":"6","key":"2020021108392693000_B19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the eastern cooperative oncology group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"2020021108392693000_B20","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2147\/CLEP.S99486","article-title":"The Danish National Chronic Lymphocytic Leukemia Registry","volume":"8","author":"da Cunha-Bang","year":"2016","journal-title":"Clin Epidemiol"},{"key":"2020021108392693000_B21","unstructured":"Christiansen\n              I\n            , PulzcynskyE, Gillstr\u00f6mD, et al. Nationale retningslinjer for kronisk lymfatisk leuk\u00e6mi. Danish Lymphoma Group, 2016 (1-20). http:\/\/www.lymphoma.dk\/wp-content\/uploads\/2016\/11\/CLL_Nationale_retningslinjer_maj_2016.pdf. Accessed 10 July, 2018."},{"issue":"2","key":"2020021108392693000_B22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jclinepi.2009.03.018","article-title":"Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution","volume":"63","author":"Severinsen","year":"2010","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"2020021108392693000_B23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"3","key":"2020021108392693000_B24","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/jth.12825","article-title":"Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality","volume":"13","author":"Ay","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2020021108392693000_B25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"issue":"6","key":"2020021108392693000_B26","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3324\/haematol.2009.005561","article-title":"Predictive value of \u03b22-microglobulin (\u03b22-m) levels in chronic lymphocytic leukemia since Binet A stages","volume":"94","author":"Gentile","year":"2009","journal-title":"Haematologica"},{"issue":"10","key":"2020021108392693000_B27","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0145-2126(99)00109-5","article-title":"Induction of beta-2-microglobulin release in vitro by chronic lymphocytic leukaemia cells: relation to total protein synthesis","volume":"23","author":"Vilpo","year":"1999","journal-title":"Leuk Res"},{"issue":"10","key":"2020021108392693000_B28","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.3324\/haematol.13103","article-title":"CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia","volume":"93","author":"Rossi","year":"2008","journal-title":"Haematologica"},{"issue":"11","key":"2020021108392693000_B29","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1182\/blood-2013-04-460139","article-title":"Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients","volume":"122","author":"Geddings","year":"2013","journal-title":"Blood"},{"issue":"4","key":"2020021108392693000_B30","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2007.02450.x","article-title":"Incidence and mortality of venous thrombosis: a population-based study","volume":"5","author":"Naess","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2020021108392693000_B31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/01.sla.0000193959.44677.48","article-title":"A clinical outcome-based prospective study on venous thromboembolism after cancer surgery","volume":"243","author":"Agnelli","year":"2006","journal-title":"Ann Surg"},{"issue":"4","key":"2020021108392693000_B32","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/annonc\/mdp354","article-title":"Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial","volume":"21","author":"Mandal\u00e0","year":"2010","journal-title":"Ann Oncol"},{"issue":"22","key":"2020021108392693000_B33","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1001\/archinte.160.22.3415","article-title":"An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study","volume":"160","author":"Samama","year":"2000","journal-title":"Arch Intern Med"},{"issue":"3","key":"2020021108392693000_B34","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1378\/chest.10-1944","article-title":"Predictive and associative models to identify hospitalized medical patients at risk for VTE","volume":"140","author":"Spyropoulos","year":"2011","journal-title":"Chest"},{"issue":"7","key":"2020021108392693000_B35","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/sj.bjc.6605883","article-title":"Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006","volume":"103","author":"Cronin-Fenton","year":"2010","journal-title":"Br J Cancer"},{"issue":"4","key":"2020021108392693000_B36","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/archinte.166.4.458","article-title":"Incidence of venous thromboembolism and its effect on survival among patients with common cancers","volume":"166","author":"Chew","year":"2006","journal-title":"Arch Intern Med"},{"issue":"4","key":"2020021108392693000_B37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10654-014-9902-7","article-title":"The increased risk of venous thromboembolism by advancing age cannot be attributed to the higher incidence of cancer in the elderly: the Troms\u00f8 study","volume":"29","author":"Blix","year":"2014","journal-title":"Eur J Epidemiol"},{"issue":"19","key":"2020021108392693000_B38","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1001\/jama.2008.656","article-title":"Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis","volume":"300","author":"Nalluri","year":"2008","journal-title":"JAMA"},{"issue":"10","key":"2020021108392693000_B39","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1002\/cncr.23062","article-title":"Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients","volume":"110","author":"Khorana","year":"2007","journal-title":"Cancer"},{"issue":"7","key":"2020021108392693000_B40","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1182\/blood-2015-01-625582","article-title":"When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English healthcare data","volume":"127","author":"Walker","year":"2016","journal-title":"Blood"},{"issue":"5","key":"2020021108392693000_B41","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1470-2045(10)70038-3","article-title":"Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden","volume":"11","author":"Van Hemelrijck","year":"2010","journal-title":"Lancet Oncol"},{"issue":"12","key":"2020021108392693000_B42","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1080\/10428194.2016.1185782","article-title":"Incidence of venous thromboembolism in patients with diffuse large B-cell lymphoma","volume":"57","author":"Borg","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"2020021108392693000_B43","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2147\/CLEP.S65681","article-title":"Quality of venous thromboembolism diagnoses among prostate cancer patients in the Danish National Registry of Patients","volume":"6","author":"Drljevic","year":"2014","journal-title":"Clin Epidemiol"},{"issue":"11","key":"2020021108392693000_B44","doi-asserted-by":"crossref","first-page":"e012832","DOI":"10.1136\/bmjopen-2016-012832","article-title":"Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study","volume":"6","author":"Sundb\u00f8ll","year":"2016","journal-title":"BMJ Open"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/21\/3025\/1629774\/advances023895.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/21\/3025\/1629774\/advances023895.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T14:14:09Z","timestamp":1581430449000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/2\/21\/3025\/16186\/Venous-thromboembolism-in-chronic-lymphocytic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,13]]},"references-count":44,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2018,11,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2018023895","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,13]]}}}